Cargando…
Labeling of Disease-Modifying Therapies for Neurodegenerative Disorders
Neurodegenerative disorders are characterized by progressive degeneration of nerve cells resulting in functional decline of cognition and/or movement. As the prevalence of many of these disorders increases with the aging global population, there is an urgent need for disease-modifying drugs that wil...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811601/ https://www.ncbi.nlm.nih.gov/pubmed/31681780 http://dx.doi.org/10.3389/fmed.2019.00223 |